Compare SNBR & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNBR | PSTV |
|---|---|---|
| Founded | 1987 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.3M | 46.4M |
| IPO Year | 1998 | 2016 |
| Metric | SNBR | PSTV |
|---|---|---|
| Price | $2.00 | $0.23 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $4.50 | ★ $6.50 |
| AVG Volume (30 Days) | 1.3M | ★ 3.3M |
| Earning Date | 03-12-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.61 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,411,450,000.00 | $5,213,000.00 |
| Revenue This Year | N/A | $21.93 |
| Revenue Next Year | $6.96 | $279.39 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.25 | $0.16 |
| 52 Week High | $13.94 | $1.22 |
| Indicator | SNBR | PSTV |
|---|---|---|
| Relative Strength Index (RSI) | 15.33 | 34.53 |
| Support Level | N/A | $0.21 |
| Resistance Level | $8.79 | $0.32 |
| Average True Range (ATR) | 0.56 | 0.02 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 0.00 | 1.84 |
Sleep Number Corp is a designer, manufacturer, marketer, and retailer, which allows it to offer consumers high-quality, individualized sleep solutions and services. It also offers FlextFit adjustable bases, and Sleep Number pillows, sheets, and other bedding products. The company generates revenue by marketing its innovations directly to new and existing customers and selling products through its Stores, Online, Phone, Chat (Total Retail), and Other. It focuses on personalized sleep wellness, with mattresses designed to evolve with each sleeper to help them feel and perform well, featuring adjustable firmness, pressure-relieving support, and temperature-balancing comfort built into every mattress. Its products include mattresses, bundles, bedding, pillows, and furniture.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).